Ticagrelor Market Size

Ticagrelor Market Growth Projections and Opportunities

The burgeoning aging population is poised to exert a positive influence on the growth of the market, primarily due to the heightened vulnerability of the elderly to chronic diseases such as arthritis, kidney diseases, and cardiovascular ailments. This demographic shift is anticipated to significantly propel market expansion, particularly in the Asia-Pacific region and other developing nations. According to data from the China National Committee on Aging, the number of individuals aged 60 and above in China was 185 million in 2014, constituting 15.7% of the population. This figure is projected to soar to 487 million by 2053, accounting for 36.5% of the population, indicative of a rising geriatric population. This demographic trend stands out as a major driving force behind the market's growth in regions undergoing rapid development.

On a global scale, statistics from the United Nations' World Population Prospects highlight that approximately 962 million individuals aged 60 and above were present worldwide in 2017, making up around 13% of the global population. The World Health Organization (WHO) estimates a nearly twofold increase in the world's population aged 60 years and older, from 12% to 22%, by the year 2050. In the United States, it is projected that over 20% of the total population will be aged 65 or over by 2030. Similarly, the United Nations predicts that Asia will accommodate around 857,040 individuals aged 60 and above by 2050. This substantial surge in the older population directly impacts the ticagrelor market, given the heightened susceptibility of the elderly to injuries and various health conditions, including gastrointestinal problems, orthopedic diseases, and other ailments arising from compromised immunity. Consequently, this demographic transition contributes to an increased frequency of hospital visits among the elderly, thereby driving the demand for medications like ticagrelor.

In summary, the escalating aging population, particularly in regions like the Asia-Pacific, stands as a pivotal factor positively influencing the growth of the ticagrelor market. The prevalence of chronic diseases among the elderly, coupled with the anticipated surge in the aging demographic worldwide, underscores the crucial role of pharmaceutical interventions like ticagrelor. As the world experiences a significant upswing in the older population, the demand for treatments addressing the unique healthcare needs of this demographic is expected to intensify, positioning ticagrelor as a key player in addressing the health challenges associated with an aging population.